Literature DB >> 26001732

The paradoxical roles of C1q and C3 in autoimmunity.

Diane Scott1, Marina Botto2.   

Abstract

In this review we will focus on the links between complement and autoimmune diseases and will highlight how animal models have provided insights into the manner by which C1q and C3 act to modulate both adaptive and innate immune responses. In particular we will highlight how C1q may not only act as initiator of the classical complement pathway, but can also mediate multiple immune responses in a complement activation independent manner.
Copyright © 2015. Published by Elsevier GmbH.

Entities:  

Keywords:  Autoimmunity; Complement; Systemic lupus erythematosus; Tolerance

Mesh:

Substances:

Year:  2015        PMID: 26001732     DOI: 10.1016/j.imbio.2015.05.001

Source DB:  PubMed          Journal:  Immunobiology        ISSN: 0171-2985            Impact factor:   3.144


  25 in total

1.  Early immune responses are independent of RGC dysfunction in glaucoma with complement component C3 being protective.

Authors:  Jeffrey M Harder; Catherine E Braine; Pete A Williams; Xianjun Zhu; Katharine H MacNicoll; Gregory L Sousa; Rebecca A Buchanan; Richard S Smith; Richard T Libby; Gareth R Howell; Simon W M John
Journal:  Proc Natl Acad Sci U S A       Date:  2017-04-26       Impact factor: 11.205

2.  Cigarette smoke-induced reduction of C1q promotes emphysema.

Authors:  Xiaoyi Yuan; Cheng-Yen Chang; Ran You; Ming Shan; Bon Hee Gu; Matthew C Madison; Gretchen Diehl; Sarah Perusich; Li-Zhen Song; Lorraine Cornwell; Roger D Rossen; Rick Wetsel; Rajapakshe Kimal; Cristian Coarfa; Holger K Eltzschig; David B Corry; Farrah Kheradmand
Journal:  JCI Insight       Date:  2019-05-21

Review 3.  New milestones ahead in complement-targeted therapy.

Authors:  Daniel Ricklin; John D Lambris
Journal:  Semin Immunol       Date:  2016-06-16       Impact factor: 11.130

Review 4.  Therapeutic control of complement activation at the level of the central component C3.

Authors:  Daniel Ricklin; John D Lambris
Journal:  Immunobiology       Date:  2015-06-10       Impact factor: 3.144

5.  Recombinant C1q variants modulate macrophage responses but do not activate the classical complement pathway.

Authors:  Victoria Espericueta; Ayla O Manughian-Peter; Isabelle Bally; Nicole M Thielens; Deborah A Fraser
Journal:  Mol Immunol       Date:  2019-11-15       Impact factor: 4.407

Review 6.  Mechanisms of antibody-mediated acute and chronic rejection of kidney allografts.

Authors:  William M Baldwin; Anna Valujskikh; Robert L Fairchild
Journal:  Curr Opin Organ Transplant       Date:  2016-02       Impact factor: 2.640

Review 7.  Complement therapeutics in inflammatory diseases: promising drug candidates for C3-targeted intervention.

Authors:  D C Mastellos; D Ricklin; E Hajishengallis; G Hajishengallis; J D Lambris
Journal:  Mol Oral Microbiol       Date:  2015-10-07       Impact factor: 3.563

Review 8.  Fundamental role of C1q in autoimmunity and inflammation.

Authors:  Myoungsun Son; Betty Diamond; Frances Santiago-Schwarz
Journal:  Immunol Res       Date:  2015-12       Impact factor: 2.829

Review 9.  Recent advances into the role of pattern recognition receptors in transplantation.

Authors:  Hrishikesh S Kulkarni; Davide Scozzi; Andrew E Gelman
Journal:  Cell Immunol       Date:  2020-03-07       Impact factor: 4.868

Review 10.  The renaissance of complement therapeutics.

Authors:  Daniel Ricklin; Dimitrios C Mastellos; Edimara S Reis; John D Lambris
Journal:  Nat Rev Nephrol       Date:  2017-12-04       Impact factor: 28.314

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.